Does the FDA approve HRT for surgical menopause

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

Yes. According to FDA.gov, hormone replacement therapy (HRT) is approved to treat menopausal symptoms, including those caused by surgical menopause. When the ovaries are removed, the sudden drop in estrogen may produce the same symptoms the FDA has long recognized and approved estrogen therapy to treat.

What the FDA Actually Approves

According to FDA.gov, the FDA does not maintain a separate approval category called "surgical menopause." Instead, it approves estrogen therapies for treating moderate to severe vasomotor symptoms (hot flashes, night sweats) and genitourinary symptoms (vaginal dryness, discomfort, urinary changes). These symptoms occur in both natural and surgical menopause, so the same FDA approvals apply.

For women who have had their ovaries removed, these symptoms may appear suddenly and often more intensely. According to FDA-approved prescribing information for estrogen therapies, estrogen therapy is recognized as an appropriate treatment for these symptoms regardless of how menopause occurred.

Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

What This Means If You Still Have Your Uterus

• If your uterus is still present: According to FDA-approved prescribing information, adding a progestogen (progesterone or a synthetic form) along with estrogen is required. This protects the uterine lining.
• If your uterus was removed: According to FDA.gov, estrogen alone is approved and considered appropriate for most women when prescribed by a qualified prescriber and used as directed.

Why HRT Is Often Especially Helpful After Surgical Menopause

• Symptoms are sudden: Without ovaries, estrogen levels may drop within days. According to FDA-approved prescribing information, HRT is approved to relieve these symptoms.
• Health considerations: Sudden estrogen loss may affect bone density, as well as other aspects of health. While FDA approval is symptom-focused, a qualified prescriber may consider additional factors based on available evidence. Note that according to FDA Drug Safety Communication, FDA boxed warnings for estrogen therapy include risks such as stroke, deep vein thrombosis, and pulmonary embolism.
• Younger women: According to NAMS, women who experience surgical menopause before the natural age of menopause may gain meaningful benefit from HRT, and the risk-benefit profile should be evaluated by a qualified prescriber.

The Bottom Line

According to FDA.gov, estrogen therapy is approved for treating menopausal symptoms, and those approvals apply to women in surgical menopause. There is no separate category because the symptoms are the same and may respond to the same commercially available treatments. Speak with a qualified prescriber to determine whether HRT is appropriate for your individual situation.